Skip to content
Home/Companies/MedTech/Equashield

Equashield

MedTech·United States·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Equashield?

Equashield is an American MedTech company, currently owned by Nordic Capital since 2022.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Capital
Investor
Nordic Capital
Nordic Capital Fund X · 2020 · Buyout

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Nordic Capital Fund X

Other portfolio companies in the same fund.

Ascot Lloyd
Active
FinancialsUK· 2022
Bilthouse
Active
FintechGermany· 2022
Care Fertility
Care Fertility
Active
HealthcareUK· 2022
One Inc
One Inc
Active
InsurTechUS· 2022
Siteimprove
Siteimprove
Active
SaaSDenmark· 2022
Zafin
Active
FintechCanada· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Equashield?

Equashield is currently owned by Nordic Capital, through Nordic Capital Fund X, since 2022.

When did Nordic Capital acquire Equashield?

Nordic Capital acquired Equashield in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue